Jennifer Banks
Family · Spokane, WANPI 1922745298
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Gilead accounts for 66.5% of it on its own, with 12 other manufacturers making up the rest. Among family clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $152.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$6K
- Boston Scientific$2K
- Astellas Pharma US Inc$125
- Phathom Pharmaceuticals, Inc.$125
- Novo Nordisk$125
- Viiv Healthcare Company$125
- plus $440 from 7 others
What the payments were for
- Consulting fees$1,44017%
- Travel & lodging$2,82333%
- Food & beverage$4,27250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 34 | $5,680 |
| Boston Scientific | 11 | $1,915 |
| Astellas Pharma US Inc | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Novo Nordisk | 1 | $125 |
| Viiv Healthcare Company | 1 | $125 |
| Abbott | 1 | $122 |
| Alk-abello, Inc | 1 | $101 |
| AstraZeneca | 1 | $81 |
| GSK | 1 | $68 |
| Edwards Lifesciences | 1 | $32 |
| AbbVie | 1 | $19 |
| Urgo Medical North America, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN Access System$1,471
- Veozah$125
- VOQUEZNA$125
- Yeztugo$125
- RYBELSUS$125
- Biktarvy$125
- DOVATO$125
- FREESTYLE LIBRE 3$122
- WATCHMAN FLX$114
How this compares
$8,534 in reported general payments places this provider in the 95th percentile of 1,706 family providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 15 | $16,077 |
| XareltoRivaroxaban | 13 | $7,870 |
| Estradiol | 19 | $1,276 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 24 | $901 |
| Gabapentin | 37 | $723 |
| Duloxetine Hcl | 18 | $634 |
| Levothyroxine Sodium | 56 | $633 |
| Rosuvastatin Calcium | 22 | $535 |
| Escitalopram Oxalate | 34 | $438 |
| Atorvastatin Calcium | 37 | $391 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $378 |
| Alendronate Sodium | 15 | $378 |
| Bupropion XlBupropion Hcl | 11 | $373 |
| Cyclobenzaprine Hcl | 37 | $359 |
| Omeprazole | 27 | $328 |
Paid to pharmacies, not to this prescriber.
Other family in Spokane
- Zelda SwainSpokane$83K
- Cheryl SomersSpokane$31K
- Lance VarnsSpokane$11K
- Ruth MolletSpokane$6K
- Robert BaylessSpokane$6K
- Jennifer NiemiSpokane$5K
- Melissa TuftsSpokane$5K
- Rachel GalazkaSpokane$5K
- Sharla PetersonKenmore$192K
- Savannah MorganRenton$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.